Get Live Data

The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Latest Share Chat

  2. Share Prices
  3. Biopharma Cred. Share Price
  4. Biopharma Cred. Share Regulatory News
  5. Notice of Full Year Results

Pin to quick picksBiopharma Cred. Regulatory News (BPCR)

Biopharma Cred. Information

Share Price Information for Biopharma Cred. (BPCR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.88
Bid: 0.878
Ask: 0.88
Change: 0.004 (0.46%)
Spread: 0.002 (0.228%)
Open: 0.88
High: 0.88
Low: 0.874
Prev. Close: 0.876
BPCR Live PriceLast checked at -
BioPharma Credit is an Investment Trust

To generate long-term shareholder returns, predominantly in the form of sustainable income distributions from exposure to the life sciences industry.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of Full Year Results

27 Feb 2024 07:00

RNS Number : 5273E
BioPharma Credit PLC
27 February 2024
 

27 February 2024

 

BIOPHARMA CREDIT PLC

(the "Company") 

NOTICE OF FULL YEAR RESULTS

 

BioPharma Credit PLC (LSE: BPCR), the specialist life sciences debt investor, will announce its audited Full Year Results for the year ended 31 December 2023 on Wednesday 27 March 2024.

A management presentation for research analysts will be delivered at 2:00pm GMT through a webcast facility. To register to attend or request details, RSVP to biopharmacredit@buchanan.uk.com.

-Ends-

 Enquiries

 BioPharma Credit PLC

via Link Company Matters Limited

Company Secretary

+44 (0) 333 300 1950

 

Buchanan

+44 (0)20 7466 5000

David Rydell / Mark Court / Jamie Hooper / Henry Wilson

biopharmacredit@buchanan.uk.com

 

Notes to Editors:

BioPharma Credit PLC is London's only listed specialist investor in debt from the life sciences industry and joined the LSE on 27 March 2017. The Company seeks to provide long-term shareholder returns, principally in the form of sustainable income distributions from exposure to the life sciences industry. The Company seeks to achieve this objective primarily through investments in debt assets secured by royalties or other cash flows derived from the sales of approved life sciences products.

LEI: 213800AV55PYXAS7SY24

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NORGZGZZGNVGDZG
12345678910
Date   Source Headline
27th Dec 20177:00 amRNSHolding(s) in Company
14th Dec 20176:30 pmRNSResults of Placing
14th Dec 20177:00 amRNSProposed Placing of Shares
13th Dec 20174:00 pmRNSNet Asset Value(s)
11th Dec 20177:00 amRNSPotential Issue of Shares
8th Dec 20175:00 pmRNSNew Investment
7th Dec 20174:45 pmRNSDividend Declaration
5th Dec 20177:00 amRNSNew Acquisition
21st Nov 20174:00 pmRNSNet Asset Value(s)
21st Nov 20171:50 pmRNSAnnouncement of First Major Investment Since IPO
13th Nov 20174:30 pmRNSHolding(s) in Company
20th Oct 20175:00 pmRNSHolding(s) in Company
20th Oct 20174:00 pmRNSNet Asset Value(s)
21st Sep 201710:03 amRNSNet Asset Value(s)
21st Sep 20177:00 amRNSHalf-year Report
24th Aug 20173:15 pmRNSNotice of Results
22nd Aug 20173:22 pmRNSNotice of Results
21st Aug 20174:00 pmRNSNet Asset Value(s)
21st Jul 20174:00 pmRNSNet Asset Value(s)
30th Jun 20174:30 pmRNSReduction of share premium account
19th Jun 20174:00 pmRNSNet Asset Value(s)
22nd May 20174:00 pmRNSNet Asset Value(s)
3rd May 20172:05 pmRNSCorrection: Final Results of Issue
25th Apr 20174:14 pmRNSNet Asset Value(s)
12th Apr 201711:24 amRNSHolding(s) in Company
6th Apr 20176:00 pmRNSCorrection: Total Voting Rights
6th Apr 20173:45 pmRNSHolding(s) in Company
6th Apr 20173:45 pmRNSHolding(s) in Company
5th Apr 20175:30 pmRNSHolding(s) in Company
5th Apr 20174:30 pmRNSHolding(s) in Company
3rd Apr 20173:00 pmRNSTotal Voting Rights
31st Mar 20176:00 pmRNSHolding(s) in Company
31st Mar 20172:15 pmRNSDirector/PDMR Shareholding
31st Mar 20171:45 pmRNSTotal Voting Rights
30th Mar 20171:00 pmRNSDirector/PDMR Shareholding
29th Mar 201711:00 amRNSHolding(s) in Company
29th Mar 201710:30 amRNSDirector/PDMR Shareholding
28th Mar 201710:30 amRNSDirector/PDMR Shareholding
28th Mar 201710:30 amRNSDirector/PDMR Shareholding
28th Mar 201710:30 amRNSDirector/PDMR Shareholding
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.